Purchase of Radiopharmaceutical I123-ioflupane AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Object of Procurement

  • What is being procured: Purchase of radiopharmaceutical I123-ioflupane including organization of transport.
  • Main technical requirements, characteristics:
    • I123-ioflupane must have a Marketing Authorization issued by the Estonian State Agency of Medicines.
    • One vial must contain at least 185 MBq of activity at the reference time specified by the purchaser.
    • The product offered must be manufactured in accordance with GMP (Good Manufacturing Practice) requirements.
    • The bidder must…
       
      To see full summary, please log in or register.
t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

294562_ESPD_v2.0_laiendatud.xml

294562_hankepass_taiendavate_selgitustega.pdf

294562_hindamiskriteeriumid.pdf

294562_vastavustingimused.pdf

294562.zip

Lisa _1_tehniline ettepanek.docx

Lisa_2_vorm_I.docx

Lisa_2_vorm_II.docx

Lisa_2_vorm_III.docx

Lisa_3_raamleping.pdf

RHAD_Radiofarmatseutikumi I123-ioflupane ostmine.pdf

Ready to get started?

Subscribe and enjoy all the benefits every day!